Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-nef Therapeutic Vaccine in HIV-1 Infected Patients
NCT00189930Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Apr 2005
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-nef in human immunodeficiency virus infection (HIV), sponsored by Bavarian Nordic. Started Apr 2005; status: completed.
02
Drugs
MVA-nef
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00189930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189930.